H.C. Wainwright Maintains Adicet Bio(ACET.US) With Hold Rating
H.C. Wainwright Remains a Hold on Adicet Bio (ACET)
Adicet Bio Analyst Ratings
H.C. Wainwright Maintains Adicet Bio(ACET.US) With Hold Rating
Adicet Bio Analyst Ratings
Guggenheim Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $7
JMP Securities Maintains Adicet Bio(ACET.US) With Hold Rating
H.C. Wainwright Maintains Adicet Bio(ACET.US) With Hold Rating
H.C. Wainwright Maintains Adicet Bio(ACET.US) With Hold Rating
Adicet Bio Analyst Ratings
H.C. Wainwright Maintains Adicet Bio(ACET.US) With Hold Rating
Guggenheim Initiates Adicet Bio(ACET.US) With Buy Rating, Announces Target Price $7
Truist Financial Maintains Adicet Bio(ACET.US) With Buy Rating
JonesTrading Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $4
Truist Financial Maintains Adicet Bio(ACET.US) With Buy Rating
A Quick Look at Today's Ratings for Adicet Bio(ACET.US), With a Forecast Between $4 to $8
Buy Rating on Adicet Bio: Promising Phase 1 GLEAN Study Results and Therapeutic Potential in NHL
Adicet Bio Analyst Ratings
Analysts Conflicted on These Healthcare Names: Teva Pharmaceutical (TEVA) and Adicet Bio (ACET)
Adicet Bio Is Maintained at Buy by Jones Trading